New York, NY, and Cincinnati, OH – Ipsos’ healthcare team
welcomes a new member of the family. Veteran researcher Mike Bandick has
joined Ipsos Understanding UnLtd., the qualitative division of Ipsos in North
America, as Vice President of Health. In this role, he will lead IUU’s qualitative
“Mike’s combination of market research experience, knowledge of the
health sector and positive, client-focused approach make him an ideal person
to lead Ipsos Understanding UnLtd.’s health sector through its next phase of
growth,” says Peter Weylie, Senior Vice President with Ipsos Understanding
UnLtd. ”Over the last two years, more and more healthcare clients are turning
to Ipsos because they know we can help them meet their biggest challenges.
Under Mike’s leadership we will continue to grow our team and build on that
Bandick brings to the role a diverse background in healthcare, including
leadership roles in both client-side and supplier-side settings. Most recently,
he spent four and half years leading the client service and analytics
(quantitative and qualitative) functions and serving on the Executive
Committee at G&S Research, a custom primary market research supplier
focused exclusively on pharmaceutical, biotechnology, medical device and
Previously, he spent 13 years in neuroscience commercialization at Eli
Lilly & Company, including global marketing director roles on two blockbuster
brands (Zyprexa® and Cymbalta®). He then went on to build the marketing
function at Suros Surgical Systems, a fast-growing medical device company
in the minimally invasive breast biopsy space.
“Ipsos’ healthcare practice is a recognized leader in the field, providing
clients with the scale, exceptional resources and the deep insight they need to
succeed in the difficult environment facing the industry today,” comments
Bandick on his decision to join Ipsos. “Being part of an innovative and growing
team is both exciting and attractive. I’m enjoying the challenge of the work, and
have been very impressed by the talent and energy of my colleagues”
A native of California, Bandick holds a bachelor’s degree from Cal Poly
Pomona and an MBA from Duke University. He resides with his wife and sons
in Zionsville, Indiana and will work closely with Ipsos Understanding UnLtd.’s
office in Cincinnati.
For more information on this news release please contact:
Ipsos Understanding UnLtd.
+1.201.574.8162 (ext: 390)
About Ipsos Understanding UnLtd.
Ipsos Understanding UnLtd. (IUU) is a full service qualitative research
firm offering a comprehensive array of highly innovative research, facilitation,
and ideation services. One of the largest and most trusted qualitative firms in
the world, IUU leverages the powerful experience of its 60+ moderators and
research consultants to deliver actionable insights for our clients in the
Consumer Packaged Goods, Retail, Healthcare/Pharma, Technology,
Financial Services, and Entertainment sectors. Moreover, IUU’s proprietary
products and techniques travel North America and globe, dovetailing
seamlessly with our clients’ quantitative efforts.
IUU partners with clients to identify the insights, innovative ideas, and
product and service concepts that help drive business.
For more information, visit us online at www.ipsos-uu.com.
Ipsos is a leading global survey-based market research company, owned
and managed by research professionals. Ipsos helps interpret, simulate, and
anticipate the needs and responses of consumers, customers, and citizens
around the world.
Member companies assess market potential and interpret market trends.
They develop and build brands. They help clients build long-term
relationships with their customers. They test advertising and study audience
responses to various media. They measure public opinion around the globe.
Ipsos member companies offer expertise in advertising, customer loyalty,
marketing, media, and public affairs research, as well as forecasting,
modeling, and consulting. Ipsos has a full line of custom, syndicated,
omnibus, panel, and online research products and services, guided by
industry experts and bolstered by advanced analytics and methodologies. The
company was founded in 1975 and has been publicly traded since 1999.
In 2009, Ipsos generated global revenues of €943.7 million ($1.31 billion
na.com to learn more about Ipsos' offerings and capabilities
Ipsos, listed on the Eurolist of Euronext – Comp B, is part of SBF 120
and the Mid-100 Index, adheres to the Next Prime segment and is eligible to
the Deferred Settlement System. Isin FR0000073298, Reuters ISOS.PA,